Detalhe da pesquisa
1.
Human seasonal coronavirus neutralization and COVID-19 severity.
J Med Virol
; 94(10): 4820-4829, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35705514
2.
Immune correlates of protection for SARS-CoV-2, Ebola and Nipah virus infection.
Front Immunol
; 14: 1156758, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37153606
3.
Pathological features of African horse sickness virus infection in IFNAR-/- mice.
Front Vet Sci
; 10: 1114240, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37065248
4.
Differential T-cell and antibody responses induced by mRNA versus adenoviral vectored COVID-19 vaccines in patients with immunodeficiencies.
J Allergy Clin Immunol Glob
; 2(2): 100091, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37038555
5.
Correlation between pseudotyped virus and authentic virus neutralisation assays, a systematic review and meta-analysis of the literature.
Front Immunol
; 14: 1184362, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37790941
6.
Clinical, Virological and Immunological Responses after Experimental Infection with African Horse Sickness Virus Serotype 9 in Immunologically Naïve and Vaccinated Horses.
Viruses
; 14(7)2022 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35891525
7.
Pseudotyped Bat Coronavirus RaTG13 is efficiently neutralised by convalescent sera from SARS-CoV-2 infected patients.
Commun Biol
; 5(1): 409, 2022 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35505237
8.
Neutralisation Hierarchy of SARS-CoV-2 Variants of Concern Using Standardised, Quantitative Neutralisation Assays Reveals a Correlation With Disease Severity; Towards Deciphering Protective Antibody Thresholds.
Front Immunol
; 13: 773982, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35330908
9.
Antibody correlates of protection from SARS-CoV-2 reinfection prior to vaccination: A nested case-control within the SIREN study.
J Infect
; 85(5): 545-556, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36089104
10.
Analysis of Serological Biomarkers of SARS-CoV-2 Infection in Convalescent Samples From Severe, Moderate and Mild COVID-19 Cases.
Front Immunol
; 12: 748291, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34867975
11.
Assessment of reproducibility of a VP7 Blocking ELISA diagnostic test for African horse sickness.
Transbound Emerg Dis
; 66(1): 83-90, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30070433
12.
Analysis of ORFs 2b, 3, 4, and partial ORF5 of sequential isolates of equine arteritis virus shows genetic variation following experimental infection of horses.
Vet Microbiol
; 129(3-4): 262-8, 2008 Jun 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-18191505
13.
The immunogenicity of recombinant vaccines based on modified Vaccinia Ankara (MVA) viruses expressing African horse sickness virus VP2 antigens depends on the levels of expressed VP2 protein delivered to the host.
Antiviral Res
; 154: 132-139, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29678552
14.
A single dose of African horse sickness virus (AHSV) VP2 based vaccines provides complete clinical protection in a mouse model.
Vaccine
; 36(46): 7003-7010, 2018 11 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30309744
15.
Vaccination and protective immunity to SARS-CoV-2 omicron variants in people with immunodeficiencies.
Lancet Microbe
; 4(2): e58-e59, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36332646
16.
Vaccination with recombinant Modified Vaccinia Ankara (MVA) viruses expressing single African horse sickness virus VP2 antigens induced cross-reactive virus neutralising antibodies (VNAb) in horses when administered in combination.
Vaccine
; 35(44): 6024-6029, 2017 10 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-28438410
17.
African horse sickness in Thailand: Challenges of controlling an outbreak by vaccination.
Equine Vet J
; 53(1): 9-14, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33007121
18.
Paucity and discordance of neutralising antibody responses to SARS-CoV-2 VOCs in vaccinated immunodeficient patients and health-care workers in the UK.
Lancet Microbe
; 2(9): e416-e418, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34223399
19.
Identification of CD8 T cell epitopes in VP2 and NS1 proteins of African horse sickness virus in IFNAR(-/-) mice.
Virus Res
; 210: 149-53, 2015 Dec 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-26272673
20.
Antiserum from mice vaccinated with modified vaccinia Ankara virus expressing African horse sickness virus (AHSV) VP2 provides protection when it is administered 48h before, or 48h after challenge.
Antiviral Res
; 116: 27-33, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25643968